5 Alejandro Hdez. USE OF MYCOPHENOLATE MOFETIL IN INFLAMMATORY BOWEL DISEASE RESULTS FROM THE ENEID | mycophenolate mofetil คือ

You are viewing this post: 5 Alejandro Hdez. USE OF MYCOPHENOLATE MOFETIL IN INFLAMMATORY BOWEL DISEASE RESULTS FROM THE ENEID | mycophenolate mofetil คือ

5 Alejandro Hdez. USE OF MYCOPHENOLATE MOFETIL IN INFLAMMATORY BOWEL DISEASE RESULTS FROM THE ENEID


นอกจากการดูบทความนี้แล้ว คุณยังสามารถดูข้อมูลที่เป็นประโยชน์อื่นๆ อีกมากมายที่เราให้ไว้ที่นี่: ดูเพิ่มเติม

5  Alejandro Hdez. USE OF MYCOPHENOLATE MOFETIL IN INFLAMMATORY BOWEL DISEASE RESULTS FROM THE ENEID

Mycophenolate mofetil therapy in Vogt-koyanagi-Harada disease


MEDICAL GRAND ROUNDS Dec. 6’16
\”Mycophenolate mofetil therapy in VogtkoyanagiHarada disease\” By: Prof. Ahmed Abu El Asrar Professor \u0026 Consultant Ophthalmologist Chief, VitreoRetina Division Department of Ophthalmology College of Medicine
King Saud University
Copyright © King Khalid Eye Specialist Hospital, All Rights Reserved

Mycophenolate mofetil therapy in Vogt-koyanagi-Harada disease

EULAR 2019 – Press conference: Rapid remission of proteinuria in lupus nephritis


The results of this study presented at the Annual European Congress of Rheumatology (EULAR 2019) suggest maintenance therapy with cyclosporine (CYA) results in more rapid remission of proteinuria compared to mycophenolate mofetil (MMF) or azathioprine (AZA) in patients with lupus nephritis. The efficacy of CYA, MMF and AZA in obtaining and maintaining remission of lupus nephritis (LN) is comparable over the long term.
Press conference title (full): Cyclosporine benefits patients through more rapid remission of proteinuria in lupus nephritis.
Spokesperson: Lorenza Maria Argolini. Rheumatology Consultant of the Lupus Clinic, ASST Pini CTO, Milan, Italy.
Abstract number: OP0046
https://www.eular.org/abstracts.cfm

EULAR 2019 - Press conference: Rapid remission of proteinuria in lupus nephritis

Mycophenolic Acid – Mycophenolate (organ transplant and DMARD) – mechanism of action, side effects


Buy PDFs here: http://armandoh.org/shop
Where do I get my information from: http://armandoh.org/resource
\”Mycophenalate is used in lupus nephritis (first line), diffuse SS but also indicated for the prophylaxis of organ rejection in patients undergoing allogeneic renal, hepatic, or cardiac transplants. In transplant patients it should be used with cyclosporine/tacrolimus and corticosteroids. Mycophenolate has a preferential inhibition of IMPDH II the rate limiting step in the de novo synthesis of guanine nucleotide from IMP in B and T lymphocytes.\”
Facebook:
https://www.facebook.com/ArmandoHasudungan
Support me:
http://www.patreon.com/armando
Instagram:
http://instagram.com/armandohasudungan
Twitter:
https://twitter.com/armandohasudung
SPECIAL THANKS:
Patreon members

Mycophenolic Acid - Mycophenolate (organ transplant and DMARD) - mechanism of action, side effects

mycophenolate mofetil by Dr Noha Ezzat


mycophenolate mofetil by Dr Noha Ezzat

นอกจากการดูหัวข้อนี้แล้ว คุณยังสามารถเข้าถึงบทวิจารณ์ดีๆ อื่นๆ อีกมากมายได้ที่นี่: ดูวิธีอื่นๆGENERAL NEWS

Articles compiled by CASTU. See more articles in category: GENERAL NEWS

Leave a Comment